OBERTHUR-TECHNOLOGIES
10.1.2017 15:28:26 CET | Business Wire | Press release
OT (Oberthur Technologies), a leading global provider of embedded security software products and services, today announces that its cutting edge solution, Lasink™ , has been chosen by Burkina Faso through a multi-year contract to supply highly secure vehicle registration documents and driving licenses.
Through a public-private partnership, Burkina Faso's Ministry of Transport, Urban Mobility and Road Safety has decided to introduce ultra-secure driving licenses and vehicle registration documents in order to improve the quality of service given to its citizens and modernise its vehicle and driver documents while combating fraud. In addition to driving licenses and vehicle registration documents, and in collaboration with local partner Megamonde, OT is supplying the enrolment and personalization system as well as the training that will enable Burkinabé citizens to benefit from the most modern and secure documents in Africa.
Using the Lasink™ solution, OT's cutting edge technology, the country's driving license photographs are laser-engraved directly onto a polycarbonate card, which prevents counterfeiting thanks to its unique functionalities. Burkina Faso is therefore able to rapidly issue tamper-proof documents with simple, quick and innovative control methods.
The technologies used by fraudsters are constantly changing and OT continues to re-invent security functions to stay one step ahead of them. Lasink™ is the only colour-photo-on-polycarbonate solution that is easy to authenticate and that remains impossible to forge. This exclusive, patented technology by OT gives the card a lifespan of 10 years as well as the greatest possible security, mainly thanks to a card body that is impossible to delaminate.
The 5-year contract between OT and Burkina Faso is based on a volume of more than 3 million cards. OT is therefore becoming a long-term partner of Burkina Faso with a high-tech industrial approach that responds to the demands of the Burkinabé government.
"We are very pleased to allow Burkina Faso to benefit from our Lasink™ technology. It's a first for Africa and we're proud of the fact that this is with Burkina Faso. Thanks to Lasink™ , the government will be able to implement a highly secure solution in order to reduce fraud and enable its citizens to authenticate themselves in a secure way and have complete confidence in their driving licenses and vehicle registration documents ", says Christophe Fontaine, Managing Director of Citizen Access & Identity Business at OT.
Burkina Faso's Minister of Transport, Urban Mobility and Road Safety, Mr Souleymane Soulama, stated: "Burkina Faso has chosen to modernise and secure the production of its vehicle and driver documents by relying on a trusted industrial and financial partner, OT, which has been able to invest in making this project possible. The country is therefore taking a major technological leap forward allowing Burkina Faso to become the first African country to benefit from OT's cutting edge technology, Lasink™ , a solution that offers increased security and reliability, while creating jobs”.
ABOUT OBERTHUR TECHNOLOGIES
OT is a world leader in embedded digital security that protects you when you connect, authenticate or pay.
OT is strategically positioned in high growth markets and offers embedded security software solutions for “end-point” devices as well as associated remote management solutions to a huge portfolio of international clients, including banks and financial institutions, mobile operators and governments, as well as manufacturers of connected objects and equipment.
OT employs over 6,500 employees worldwide, including almost 700 R&D people. With a global footprint of 4 regional secure manufacturing hubs and 39 secure service centres, OT’s international network serves clients in 169 countries. For more information: www.oberthur.com
Download
The
M World
,
All you need to know about the latest
trends of the Mobility world, available on AppStore and Google Play
www.oberthur.com/themworld
FOLLOW US ON SOCIAL NETWORKS
Twitter
LinkedIn
View source version on businesswire.com: http://www.businesswire.com/news/home/20170110005817/en/
Contact:
MEDIA CONTACTS:
Elan-Edelman
Chloé
Tisseuil, Tel. +33 1 86 21 50 54
chloe.tisseuil@elanedelman.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Together AI and HUMAIN Form Strategic Partnership to Accelerate AI Infrastructure and Cloud Services in Saudi Arabia31.8.2026 14:00:00 CEST | Press release
The partnership, which was announced on stage at LEAP, Combines HUMAIN’s AI Infrastructure Foundation with Together’s AI Native Cloud Platform and Global Reach Together AI, a leading San Francisco-based AI Native Cloud platform, and HUMAIN, a PIF company delivering full-stack artificial intelligence capabilities globally, today at LEAP announced a strategic partnership to connect HUMAIN’s rapidly expanding AI compute capacity in Saudi Arabia with global AI-native and enterprise demand. The partnership will include the construction of a new 250 megawatt data center, located in Saudi Arabia. The partnership brings together HUMAIN’s large-scale, multi-chip AI infrastructure footprint, expanding cloud and inference capabilities with Together AI’s global customer ecosystem and AI-native inference platform. Together, the companies will offer an additional option for developers, enterprises, and AI-native organizations worldwide to access high-performance AI infrastructure for inference and t
SLB to Acquire Kelvion, Expanding its Role Across Data Center Infrastructure31.8.2026 12:50:00 CEST | Press release
Scalable, energy-efficient and reliable thermal management technologies will optimize operating performance in increasingly complex data centers and industrial systems SLB (NYSE: SLB) today announced it has signed an agreement to acquire Kelvion, a global provider of thermal management and heat exchange technologies. The acquisition strengthens SLB's Data Center Solutions business with critical thermal management technologies and expands the company's role in data center infrastructure, which is one of the world’s fastest-growing industrial and technology markets. “AI is driving the most significant infrastructure investment cycle in our lifetime,” said Olivier Le Peuch, chief executive officer of SLB. “This transaction accelerates our ambition to become an industrial technology partner to the data center industry and help customers address the growing infrastructure complexity required to scale AI. Kelvion advances our path toward more integrated data center infrastructure solutions,
BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer31.8.2026 12:00:00 CEST | Press release
Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEAZIIHERA plus chemotherapy demonstrated statistically significant overall survival benefit at second interim analysis of HERIZON-GEA-01 trial BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA® (tislelizumab), as first-line treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). At IA2, ZIIHERA plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared with trastuzumab plus chemotherapy, meeting the remaining primary endpoint analysis of the study. IA2 also provided longer follow-up data for the TEVIMBRA plus ZIIHERA
GigaDevice Strengthens EMEA and Southeast Asia Market Reach Through Strategic Partnership with Rutronik31.8.2026 09:00:00 CEST | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today announced a new strategic franchise partnership with Rutronik Elektronische Bauelemente GmbH, one of Europe’s leading broadline distributors of electronic components. The agreement covers EMEA and Southeast Asia, including India, and provides customers with broader access to GigaDevice’s comprehensive portfolio of microcontrollers, sensors, and power management solutions. The partnership further strengthens GigaDevice’s distribution network and local market presence across key regions. With its strong presence across Europe and growing coverage in Southeast Asia, Rutronik provides GigaDevice with an established channel supported by extensive market reach, technical expertise, and customer relationships. The collaboration will help expand access to GigaDevice’s embedded solutions across a broad range of applications and industries, including indus
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release
–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
